Fidelity Investments
CRBU icon

Fidelity Investments’s Caribou Biosciences CRBU Stock Holding History

Fidelity Investments’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
727,115
+3,156
+0.4% +$6.24K ﹤0.01% 2910
2026
Q1 		$1.38M Sell
723,959
-2,009
-0.3% -$3.45K ﹤0.01% 2758
2025
Q4 		$1.15M Sell
725,968
-3,034
-0.4% -$6.37K ﹤0.01% 2803
2025
Q3 		$1.7M Sell
729,002
-439
-0.1% -$829 ﹤0.01% 2604
2025
Q2 		$919K Sell
729,441
-730,657
-50% -$719K ﹤0.01% 2748
2025
Q1 		$1.33M Sell
1,460,098
-187,107
-11% -$243K ﹤0.01% 2583
2024
Q4 		$2.62M Buy
1,647,205
+65,712
+4% +$132K ﹤0.01% 2354
2024
Q3 		$3.1M Buy
1,581,493
+109,606
+7% +$224K ﹤0.01% 2277
2024
Q2 		$2.41M Buy
1,471,887
+26,725
+2% +$85.4K ﹤0.01% 2296
2024
Q1 		$7.43M Buy
1,445,162
+586
+0% +$3.61K ﹤0.01% 1962
2023
Q4 		$8.28M Sell
1,444,576
-619
-0% -$3.06K ﹤0.01% 1910
2023
Q3 		$6.91M Buy
1,445,195
+2,007
+0.1% +$12.5K ﹤0.01% 1940
2023
Q2 		$6.13M Sell
1,443,188
-635
-0% -$2.85K ﹤0.01% 2005
2023
Q1 		$7.67M Buy
1,443,823
+777
+0.1% +$4.84K ﹤0.01% 1972
2022
Q4 		$9.06M Sell
1,443,046
-547
-0% -$4.87K ﹤0.01% 1931
2022
Q3 		$15.2M Sell
1,443,593
-80,742
-5% -$752K ﹤0.01% 1708
2022
Q2 		$8.28M Sell
1,524,335
-488,698
-24% -$3.74M ﹤0.01% 2049
2022
Q1 		$18.5M Sell
2,013,033
-1,310,251
-39% -$13.8M ﹤0.01% 1815
2021
Q4 		$50.1M Hold
3,323,284
– – ﹤0.01% 1421
2021
Q3 		$79.3M Buy
+3,323,284
New +$81.2M 0.01% 1202

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments's CRBU Position: Q2 2026 in Review

Fidelity Investments increased its Caribou Biosciences (CRBU) stake by 0.44% in Q2 2026, buying an estimated $6.24K and bringing the position to 727,115 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2910.

Fidelity Investments first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $79.3M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Fidelity Investments held 727,115 shares of Caribou Biosciences worth $1.28M as of Q2 2026.
  • Fidelity Investments bought 3,156 Caribou Biosciences shares in Q2 2026, an estimated $6.24K.
  • Caribou Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2910 holding.
  • Fidelity Investments first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Caribou Biosciences position peaked at $79.3M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.